drugset / Trial / NCT00439699
A Pilot Clinical Trial Of Memantine for Essential Tremor
Phase 4
Completed
16 enrolled
VA Greater Los Angeles Healthcare System
Forest Laboratories · collabRalph M. Parsons Foundation · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to obtain information on whether or not the medication Memantine reduces tremor in persons with essential tremor and is well-tolerated.
Timeline
- Start
- 2007-02
- Primary completion
- 2008-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Memantine | Unknown | 40 mg | — |